Insider Trading & Ownership of Christopher Haqq

Location: Brisbane, CA
Summary: The estimated net worth of Christopher Haqq is at least $468,152 dollars as of 03 Feb 2026. Christopher Haqq is the Executive Vice President, Head of R&D and Chief Medical Officer of Elicio Therapeutics, Inc. and owns shares of Elicio Therapeutics, Inc. (ELTX) stock worth about $456.8K. Christopher Haqq is the Former Director of Surrozen, Inc./DE and owns shares of Surrozen, Inc./DE (SRZN) stock worth about $11.4K.
Signature: /s/ Christopher Haqq
All Insider Reports: All Insider Reports

Notify me when Christopher Haqq files a new Insider Trading report.

Ownership of Christopher Haqq

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ELTX	Elicio Therapeutics, Inc.	Executive Vice President, Head of R&D and Chief Medical Officer	$456,752			02 Feb 2026
SRZN, SRZNW	Surrozen, Inc./DE	Former Director	$11,400			11 Aug 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.